Detection of human cytomegalovirus DNA by real-time quantitative PCR

被引：45
作者：
Nitsche, A
Steuer, N
Schmidt, CA
Landt, O
Ellerbrok, H
Pauli, G
Siegert, W
机构：
[1] Humboldt Univ, Klin Innere Med MS Hamatol & Onkol, D-13353 Berlin, Germany
[2] Robert Koch Inst, TIB Molbiol, D-1000 Berlin, Germany
[3] Robert Koch Inst, Dept Virol, D-1000 Berlin, Germany
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2000年 / 38卷 / 07期
关键词：
D O I：
10.1128/JCM.38.7.2734-2737.2000
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A real-time PCR assay was developed to quantify human cytomegalovirus (CMV) DNA. This assay was used to demonstrate a higher CMV DNA load in plasma of bone marrow transplant patients than in that of blood donors. The CMV load was higher in CMV antigen-positive patients than in antigen-negative patients.
引用
收藏
页码：2734 / 2737
页数：4
相关论文
共 16 条
  • [1] Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects
    Boivin, G
    Handfield, J
    Toma, E
    Murray, G
    Lalonde, R
    Tevere, VJ
    Sun, R
    Bergeron, MG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (09) : 2509 - 2513
  • [2] DUMMER JS, 1990, REV INFECT DIS, V12, pS767
  • [3] TREATMENT OF INVASIVE CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT PATIENTS WITH GANCICLOVIR
    DUNN, DL
    MAYORAL, JL
    GILLINGHAM, KJ
    LOEFFLER, CM
    BRAYMAN, KL
    KRAMER, MA
    ERICE, A
    BALFOUR, HH
    FLETCHER, CV
    BOLMAN, RM
    MATAS, AJ
    PAYNE, WD
    SUTHERLAND, DER
    NAJARIAN, JS
    [J]. TRANSPLANTATION, 1991, 51 (01) : 98 - 106
  • [4] EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GOODRICH, JM
    MORI, M
    GLEAVES, CA
    DUMOND, C
    CAYS, M
    EBELING, DF
    BUHLES, WC
    DEARMOND, B
    MEYERS, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) : 1601 - 1607
  • [5] Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
    Gor, D
    Sabin, C
    Prentice, HG
    Vyas, N
    Man, S
    Griffiths, PD
    Emery, VC
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (06) : 597 - 605
  • [6] GANCICLOVIR THERAPY OF SEVERE CYTOMEGALO-VIRUS INFECTIONS IN SOLID-ORGAN TRANSPLANT RECIPIENTS
    HARBISON, MA
    DEGIROLAMI, PC
    JENKINS, RL
    HAMMER, SM
    [J]. TRANSPLANTATION, 1988, 46 (01) : 82 - 88
  • [7] DETECTION OF SPECIFIC POLYMERASE CHAIN-REACTION PRODUCT BY UTILIZING THE 5'-]3' EXONUCLEASE ACTIVITY OF THERMUS-AQUATICUS DNA-POLYMERASE
    HOLLAND, PM
    ABRAMSON, RD
    WATSON, R
    GELFAND, DH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) : 7276 - 7280
  • [8] Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time
    Larsson, S
    Söderberg-Nauclér, C
    Wang, FZ
    Möller, E
    [J]. TRANSFUSION, 1998, 38 (03) : 271 - 278
  • [9] Nitsche A, 1999, CLIN CHEM, V45, P1932
  • [10] Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients
    Roberts, TC
    Brennan, DC
    Buller, RS
    Gaudreault-Keener, M
    Schnitzler, MA
    Sternhell, KE
    Garlock, KA
    Singer, GG
    Storch, GA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) : 626 - 635
12